Clinical Trial Update: Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery [Phase 3]

View source ↗

Summary

Phase 3 study of Wilate for preventing bleeding in Von Willebrand disease patients undergoing major surgery has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• Wilate (von Willebrand factor/factor VIII concentrate)

Snippet

Sponsor: Octapharma | Conditions: Prevent Bleeding in Major Surgery | Phase 3 | Status: COMPLETED | Results posted: 2015-03-09